Effect of intestinal microbiota on liver disease and its related future prospection: From the perspective of intestinal barrier damage and microbial metabolites
- 30 January 2023
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (7), 1056-1071
- https://doi.org/10.1111/jgh.16129
Abstract
Liver diseases contribute notably to the global concern of mortality and disease. Emerging evidence has demonstrated that intestinal microbiota can regulate intestinal barrier function and produce bioactive metabolites. Failure of any aspect of this barrier can result in the translocation of microbes into the blood and a sustained inflammatory response that promotes liver injury, fibrosis, and cirrhosis. Here, we review the mechanisms by that intestinal microbiota regulate the intestinal barrier. The multiple underlying mechanisms of intestinal microbiota in liver disease are elaborated in detail, emphasizing them as the bridge linking the liver with gut microbiota. Thus, we highlight the feasibility of targeting the gut-liver axis for treating liver diseases.Keywords
Funding Information
- National Natural Science Foundation of China (82270643, 82170621, 82070644, 81800564, 81770615)
This publication has 103 references indexed in Scilit:
- Dissecting negative regulation of Toll-like receptor signalingTrends in Immunology, 2012
- Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteinsWorld Journal of Gastroenterology, 2012
- Valproic acid alters mitochondrial cholesterol transport in Y1 adrenocortical cellsToxicology in Vitro, 2011
- Negative regulation of Toll‐like receptor signaling plays an essential role in homeostasis of the intestineEuropean Journal of Immunology, 2010
- Helicobacter pylori-Induced Th17 Responses Modulate Th1 Cell Responses, Benefit Bacterial Growth, and Contribute to Pathology in MiceThe Journal of Immunology, 2010
- Rat Strain Differences in Susceptibility to Alcohol-Induced Chronic Liver Injury and Hepatic Insulin ResistanceGastroenterology Research and Practice, 2010
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver diseaseJournal of Hepatology, 2009
- The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal TractApplied and Environmental Microbiology, 2008
- Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cellsNature, 2006
- A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundiceJournal of Hepatology, 2003